Left Main and Bifurcation treatment:
impact of clinical trials in daily practice
5 juillet 2023 - 18h00 - 19h00
impact of clinical trials in daily practice
Agenda
Hours are indicated in CET
|
6.00 pm
|
Welcome and Introduction
Prof. Jens Lassen |
| 6.05 |
Key messages of EBC Main 3Y, EBC TWO 5Y and Rolex 2Y
Prof. David Hildick-Smith |
| 6.15 |
Left Main case requiring one stent
Prof. Jens Lassen |
| 6.25 |
Key messages of CRABBIS study
Prof. Francesco Burzotta |
| 6.35 |
Case of bifurcation lesion treatment with two stenting technique
Prof. Sa'ar Minha
|
| 6.50 | Key messages of MOBBEM study Prof. Francesco Burzotta |
| 7.00 pm | Discussion and key messages Prof. Jens Lassen |
Educational objectives
A cased-based discussion on the impact on clinical practice of:
- EBC Main trial at 3 years: the Largest prospective study on left main (LM) PCI with a DES that has a dedicated extra-large stent platform
- EBC TWO trial at 5 years: A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations
- Rolex Study at 2 years: the First randomised trial based on European Bifurcation Club (EBC) consensus, comparing a provisional to a planned, dual-stent strategy, LM bifurcation PCI
- MOBBEM study: Configuration of two-stent coronary bifurcation techniques in explanted beating hearts. Cases were performed in the Visible Heart Lab in Minneapolis.
- CRABBIS Study: The objective of this study is to compare the configuration achieved with POT/KISS/POT (PKP) and POT/SIDE/POT (PSP), using the « cutting edge » high-resolution intracoronary imaging modality (Optical Coherence Tomography, OCT)